Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on September 3, 2025
Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting
GlobeNewswire
·
September 3, 2025
WILMETTE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 3, 2025
BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the H.C. Wainwright 27th Annual Global Investment …
Satellogic Signs Exclusive Seven-Figure Agreement with Suhora to Expand Earth Observation Data Services in India
GlobeNewswire
·
September 3, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in sub-meter resolution Earth Observation (“EO”) data, today announced it has entered into a strategic, multi-year partnership with Suhora, a leading provider of dual-use …
LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer
GlobeNewswire
·
September 3, 2025
-- Company Relocates Corporate Headquarters to Boca Raton -- Boca Raton, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a …
Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
GlobeNewswire
·
September 3, 2025
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it will have two oral presentations, …
Locafy’s AI Sales Team Delivers Strong Initial Results, Validating Scalable Go-to-Market Model
GlobeNewswire
·
September 3, 2025
Perth, Australia, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Locafy Limited (NASDAQ: LCFY) (“Locafy” or the “Company”), a globally recognized software-as-a-service technology company specializing in location-based digital marketing solutions, today announced …
Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee
GlobeNewswire
·
September 3, 2025
PiNACLE - H2H will evaluate rondecabtagene autoleucel (ronde-cel) versus investigator’s choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell lymphoma receiving treatment in the second line (2L) setting Ronde-cel is Lyell’s …
Duos Edge AI Awarded Patent
GlobeNewswire
·
September 3, 2025
JACKSONVILLE, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data …
Genius Group CEO Roger Hamilton to speak at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
SINGAPORE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced its CEO, Roger Hamilton, will be speaking at the H.C. Wainwright …
Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance
GlobeNewswire
·
September 3, 2025
Company on Friday, August 29, 2025, filed quarterly reports on Form 10-Q for the periods ended March 31, 2025, and June 30, 2025, respectively, in accord with its August 11, 2025 updated Nasdaq compliance plan. Company also announces notification by Nasdaq …
Echobit Secures Czech VASP License and Partners with Coinone to Enhance Crypto Deposit and Withdrawal Services
GlobeNewswire
·
September 3, 2025
Singapore, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Echobit exchange has reached a “dual milestone” in its global compliance journey — obtaining a Virtual Asset Service Provider (VASP) registration in the Czech Republic and forming a strategic partnership with …
Free Mark Cuban Foundation AI Bootcamp Coming to Philadelphia This Fall
GlobeNewswire
·
September 3, 2025
PHILADELPHIA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with CSL, will host a no-cost Artificial Intelligence Bootcamp for high school students in Philadelphia this fall. The program is open to students in grades 9–12 and …
Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target
GlobeNewswire
·
September 3, 2025
PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study has …
BridgeBio to Host Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar on Wednesday, September 10th at 8:00 am ET
GlobeNewswire
·
September 3, 2025
PALO ALTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on …
Shock Top and Auntie Anne’s® Make It Official - Beer Kneads Pretzels
GlobeNewswire
·
September 3, 2025
ATLANTA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), known for its bold flavors and unfiltered wheat ales, and the world’s largest hand-rolled soft pretzel franchise …
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
EMERYVILLE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will present a company …
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 3, 2025
DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a …
Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum
GlobeNewswire
·
September 3, 2025
SAN FRANCISCO and BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, …
Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland
GlobeNewswire
·
September 3, 2025
This marks the first export of organic certified flower for SMGH, 20th international market for Aureus branded products and 23rd market for all Avicanna products TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: …
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
GlobeNewswire
·
September 3, 2025
Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 µM total AAT, 7.2 µM M-AAT) First-ever demonstration of therapeutically restored …